GSK, others eyeing acquisition of Brazil's 4th largest drugmaker

02/12/2013 | Reuters

Several drugmakers, including GlaxoSmithKline and likely Novartis, Pfizer and Abbott Laboratories, are looking at acquiring Brazil's Ache Laboratorios Farmaceuticos for up to $4 billion to increase their share in Latin America's pharmaceutical industry. Ache is the fourth-largest drugmaker in Brazil, but it ranks first in prescription drugs and is growing its over-the-counter business.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Medical Director - Cataract
Abbott
Santa Ana, CA
Director/Vice President, FDA Strategy and Regulatory Policy
Avalere Health
Washington, DC
Manager, Compliance
Stryker
Fremont, CA